<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HFE5077FF82134BA299038E51CF912F93" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 4392 IH: Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-07-15</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 4392</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250715">July 15, 2025</action-date><action-desc><sponsor name-id="B001313">Ms. Brown</sponsor> (for herself, <cosponsor name-id="C001067">Ms. Clarke of New York</cosponsor>, <cosponsor name-id="S001185">Ms. Sewell</cosponsor>, <cosponsor name-id="F000477">Mrs. Foushee</cosponsor>, <cosponsor name-id="M001227">Ms. McClellan</cosponsor>, <cosponsor name-id="V000081">Ms. Velázquez</cosponsor>, <cosponsor name-id="F000110">Mr. Fields</cosponsor>, <cosponsor name-id="K000385">Ms. Kelly of Illinois</cosponsor>, <cosponsor name-id="D000624">Mrs. Dingell</cosponsor>, <cosponsor name-id="T000481">Ms. Tlaib</cosponsor>, <cosponsor name-id="T000482">Mrs. Trahan</cosponsor>, <cosponsor name-id="J000288">Mr. Johnson of Georgia</cosponsor>, <cosponsor name-id="A000381">Ms. Ansari</cosponsor>, <cosponsor name-id="W000822">Mrs. Watson Coleman</cosponsor>, <cosponsor name-id="S001157">Mr. David Scott of Georgia</cosponsor>, <cosponsor name-id="T000488">Mr. Thanedar</cosponsor>, <cosponsor name-id="T000193">Mr. Thompson of Mississippi</cosponsor>, <cosponsor name-id="K000391">Mr. Krishnamoorthi</cosponsor>, <cosponsor name-id="S001226">Ms. Salinas</cosponsor>, <cosponsor name-id="M001229">Mrs. McIver</cosponsor>, <cosponsor name-id="C001125">Mr. Carter of Louisiana</cosponsor>, <cosponsor name-id="M001188">Ms. Meng</cosponsor>, <cosponsor name-id="W000808">Ms. Wilson of Florida</cosponsor>, <cosponsor name-id="L000602">Ms. Lee of Pennsylvania</cosponsor>, <cosponsor name-id="S001231">Ms. Simon</cosponsor>, <cosponsor name-id="W000797">Ms. Wasserman Schultz</cosponsor>, <cosponsor name-id="F000481">Mr. Figures</cosponsor>, <cosponsor name-id="A000370">Ms. Adams</cosponsor>, <cosponsor name-id="K000389">Mr. Khanna</cosponsor>, <cosponsor name-id="U000040">Ms. Underwood</cosponsor>, <cosponsor name-id="G000553">Mr. Green of Texas</cosponsor>, <cosponsor name-id="T000487">Ms. Tokuda</cosponsor>, <cosponsor name-id="R000620">Ms. Rivas</cosponsor>, <cosponsor name-id="M001231">Mr. Mannion</cosponsor>, <cosponsor name-id="P000617">Ms. Pressley</cosponsor>, <cosponsor name-id="T000468">Ms. Titus</cosponsor>, and <cosponsor name-id="L000606">Mr. Latimer</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes.</official-title></form><legis-body id="H4545CADAA81E4EB6AF93630F0BE296AF" style="OLC"> 
<section id="HC1FF584AE633454095078E0EEAFFC210" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025</short-title></quote>.</text></section> <section id="H7FC693FD69F54F84A392734840654B2A"><enum>2.</enum><header>Research on uterine fibroid early detection and intervention</header> <subsection id="HCAE91138D5464035B1E8F109D1DF033B"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services (in this Act referred to as the <quote>Secretary</quote>) shall—</text>
<paragraph id="H5EAB749B4FAB445080C8D09B6E0B90BD"><enum>(1)</enum><text>conduct or support research on increasing early detection of, and intervention for, uterine fibroids; and</text></paragraph> <paragraph id="H8AAC7E6ABC254DD4B4E60C118CD23FE6"><enum>(2)</enum><text>based on the results of such research and other relevant information, formulate evidence-based or evidence-informed strategies to increase early detection in health care settings.</text></paragraph></subsection>
<subsection id="H7419EFEC5ED34420B6493FBF34F1113A"><enum>(b)</enum><header>Timeline</header><text display-inline="yes-display-inline">The Secretary shall finalize the evidence-based or evidence-informed strategies required by subsection (a)(2) as expeditiously as possible in order to make such strategies available to grantees under section 3 to implement such strategies pursuant to section 3(b)(3).</text></subsection></section> <section id="H5C3EAE3578784812B054FEE771D21012"><enum>3.</enum><header>Grants with respect to uterine fibroid early detection and intervention</header> <subsection id="H21AAD38E22B54BCA81C1504764D8D7AB"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">The Secretary of Health and Human Services (in this Act referred to as the <quote>Secretary</quote>) may award grants to States for carrying out programs—</text>
<paragraph id="H2BCFEE9DBA7E4780807E2A83F85D615F"><enum>(1)</enum><text>to increase early detection of and intervention for uterine fibroids; and</text></paragraph> <paragraph id="H6A9BCE71939A40EBA6CC912F75D36144"><enum>(2)</enum><text>to develop and implement public awareness and education campaigns for the early detection and intervention of uterine fibroids.</text></paragraph></subsection>
<subsection id="HE062BF2BF3BC42E3B6D4A1E6B3872700"><enum>(b)</enum><header>Use of funds</header><text>A State receiving a grant under this section may use the grant, with respect to increasing early detection of and intervention for uterine fibroids, for the following activities:</text> <paragraph id="H30DFDE3746634872AA355CD4C0A7C47E"><enum>(1)</enum><text>Screening procedures, including advanced gynecological imaging (including payment therefor).</text></paragraph>
<paragraph id="H97211E9D149F4758B7D7F94D8485AF08"><enum>(2)</enum><text>Patient navigation services.</text></paragraph> <paragraph id="H84B2A4035166413C9F24E0746185B100"><enum>(3)</enum><text>Implementation of evidence-based or evidence-informed strategies proven to increase early detection in health care settings.</text></paragraph>
<paragraph id="HC16B809C97E34ED2B0959FC827A54701"><enum>(4)</enum><text>Facilitating access to health care settings.</text></paragraph></subsection> <subsection id="HD2456684C11946579502B79D393AB8D0"><enum>(c)</enum><header>Priority</header><text display-inline="yes-display-inline">In awarding grants under this section, the Secretary shall give priority to States proposing to carry out a program in a geographic areas in which there are socially vulnerable populations with elevated risk of uterine fibroid development.</text></subsection></section>
<section id="H165B91D718A24C72A1CB0D69EC99A42E"><enum>4.</enum><header>Research with respect to uterine fibroid early detection and intervention</header><text display-inline="no-display-inline">The Secretary may award grants to conduct research, which may include clinical trials, related to—</text> <paragraph id="H2903665B6AAE4739B40420198E5D05E7"><enum>(1)</enum><text>disparities in pain control and management in uterine fibroid surgical treatment; or</text></paragraph>
<paragraph id="H7B48623324D0476A939A7C88CCFD5516"><enum>(2)</enum><text>Asherman’s Syndrome, intrauterine adhesions, and other intrauterine conditions as determined appropriate by the Secretary.</text></paragraph></section> <section id="HEBCF66B151EF4878A027E78AACB9A9C5"><enum>5.</enum><header>Reports to Congress</header> <subsection id="H1647FF0DCF95405B82A492C857C6D4C5"><enum>(a)</enum><header>Reports on grants</header><text>Not later 2 years after the initial award of grants under this Act, and every 2 years thereafter, the Secretary shall submit to the Congress, and make publicly available on the appropriate website of the Department of Health and Human Services, a report summarizing the findings and results of programs and activities funded through grants under this Act.</text></subsection>
<subsection id="H9BABAC7618A84D1C828DF5516C441B78"><enum>(b)</enum><header>Report on research developments</header><text display-inline="yes-display-inline">Not later than 2 years after the date of enactment of this Act, and every 2 years thereafter, the Secretary shall submit to the Congress, and make publicly available on the appropriate website of the Department of Health and Human Services, a report outlining research developments and findings related to—</text> <paragraph id="HC4336714CFE54ABA9AB94CF8CD50ECE0"><enum>(2)</enum><text>disparities in pain control and management in uterine fibroid surgical treatment; and</text></paragraph>
<paragraph id="HA29DED0465AC4A8FAC3BB0D4EB2A16A7"><enum>(3)</enum><text display-inline="yes-display-inline">Asherman’s Syndrome, intrauterine adhesions, and other intrauterine conditions as determined appropriate by the Secretary.</text></paragraph></subsection></section> </legis-body></bill>

